Impact of Population-Based Pathogenic Variant Testing on Risk-Based Breast Screening Recommendations: A Secondary Analysis of the WISDOM Study.
Saved in:
| Title: | Impact of Population-Based Pathogenic Variant Testing on Risk-Based Breast Screening Recommendations: A Secondary Analysis of the WISDOM Study. |
|---|---|
| Authors: | Shieh Y; Department of Population Health Sciences, Weill Cornell Medicine, New York, New York., Heise RS; Department of Population Health Sciences, Weill Cornell Medicine, New York, New York., Madlensky L; Division of Genomics and Precision Medicine, Department of Medicine, University of California, San Diego, La Jolla., Sabacan LP; Department of Surgery, University of California, San Francisco., Soto IA; Department of Surgery, University of California, San Francisco., Fiscalini AS; Department of Surgery, University of California, San Francisco., Ross K; Cancer Genetics and Prevention Program, University of California, San Francisco., Goodman D; Department of Epidemiology, University of California, Irvine., Blanco A; Cancer Genetics and Prevention Program, University of California, San Francisco., Brain S; UCSF Breast Science Advocacy Core, San Francisco, California., Heditsian DM; UCSF Breast Science Advocacy Core, San Francisco, California., Moya J; Department of Surgery, University of California, San Francisco., Fergus KB; Department of Surgery, University of California, San Francisco., Olopade OI; Center for Innovation in Global Health, Section of Hematology/Oncology, Department of Medicine, The University of Chicago, Chicago, Illinois., Scheuner MT; San Francisco VA Health Care System, San Francisco, California., Eklund M; Karolinska Institute, Stockholm, Sweden., Ziv E; Department of Medicine, University of California, San Francisco., Tice JA; Department of Medicine, University of California, San Francisco., van 't Veer L; Department of Laboratory Medicine, University of California, San Francisco., Esserman LJ; Department of Surgery, University of California, San Francisco. |
| Corporate Authors: | Athena Breast Health Network and WISDOM Study Investigators and Advocate Partners |
| Source: | JAMA oncology [JAMA Oncol] 2026 May 31. Date of Electronic Publication: 2026 May 31. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: American Medical Association Country of Publication: United States NLM ID: 101652861 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2374-2445 (Electronic) Linking ISSN: 23742437 NLM ISO Abbreviation: JAMA Oncol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 42218736 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Impact of Population-Based Pathogenic Variant Testing on Risk-Based Breast Screening Recommendations: A Secondary Analysis of the WISDOM Study. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Shieh+Y%22">Shieh Y</searchLink>; Department of Population Health Sciences, Weill Cornell Medicine, New York, New York.<br /><searchLink fieldCode="AU" term="%22Heise+RS%22">Heise RS</searchLink>; Department of Population Health Sciences, Weill Cornell Medicine, New York, New York.<br /><searchLink fieldCode="AU" term="%22Madlensky+L%22">Madlensky L</searchLink>; Division of Genomics and Precision Medicine, Department of Medicine, University of California, San Diego, La Jolla.<br /><searchLink fieldCode="AU" term="%22Sabacan+LP%22">Sabacan LP</searchLink>; Department of Surgery, University of California, San Francisco.<br /><searchLink fieldCode="AU" term="%22Soto+IA%22">Soto IA</searchLink>; Department of Surgery, University of California, San Francisco.<br /><searchLink fieldCode="AU" term="%22Fiscalini+AS%22">Fiscalini AS</searchLink>; Department of Surgery, University of California, San Francisco.<br /><searchLink fieldCode="AU" term="%22Ross+K%22">Ross K</searchLink>; Cancer Genetics and Prevention Program, University of California, San Francisco.<br /><searchLink fieldCode="AU" term="%22Goodman+D%22">Goodman D</searchLink>; Department of Epidemiology, University of California, Irvine.<br /><searchLink fieldCode="AU" term="%22Blanco+A%22">Blanco A</searchLink>; Cancer Genetics and Prevention Program, University of California, San Francisco.<br /><searchLink fieldCode="AU" term="%22Brain+S%22">Brain S</searchLink>; UCSF Breast Science Advocacy Core, San Francisco, California.<br /><searchLink fieldCode="AU" term="%22Heditsian+DM%22">Heditsian DM</searchLink>; UCSF Breast Science Advocacy Core, San Francisco, California.<br /><searchLink fieldCode="AU" term="%22Moya+J%22">Moya J</searchLink>; Department of Surgery, University of California, San Francisco.<br /><searchLink fieldCode="AU" term="%22Fergus+KB%22">Fergus KB</searchLink>; Department of Surgery, University of California, San Francisco.<br /><searchLink fieldCode="AU" term="%22Olopade+OI%22">Olopade OI</searchLink>; Center for Innovation in Global Health, Section of Hematology/Oncology, Department of Medicine, The University of Chicago, Chicago, Illinois.<br /><searchLink fieldCode="AU" term="%22Scheuner+MT%22">Scheuner MT</searchLink>; San Francisco VA Health Care System, San Francisco, California.<br /><searchLink fieldCode="AU" term="%22Eklund+M%22">Eklund M</searchLink>; Karolinska Institute, Stockholm, Sweden.<br /><searchLink fieldCode="AU" term="%22Ziv+E%22">Ziv E</searchLink>; Department of Medicine, University of California, San Francisco.<br /><searchLink fieldCode="AU" term="%22Tice+JA%22">Tice JA</searchLink>; Department of Medicine, University of California, San Francisco.<br /><searchLink fieldCode="AU" term="%22van+'t+Veer+L%22">van 't Veer L</searchLink>; Department of Laboratory Medicine, University of California, San Francisco.<br /><searchLink fieldCode="AU" term="%22Esserman+LJ%22">Esserman LJ</searchLink>; Department of Surgery, University of California, San Francisco. – Name: AuthorCorporate Label: Corporate Authors Group: Au Data: <searchLink fieldCode="CA" term="%22Athena+Breast+Health+Network+and+WISDOM+Study+Investigators+and+Advocate+Partners%22">Athena Breast Health Network and WISDOM Study Investigators and Advocate Partners</searchLink> – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101652861%22">JAMA oncology</searchLink> [JAMA Oncol] 2026 May 31. <i>Date of Electronic Publication: </i>2026 May 31. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22American+Medical+Association%22">American Medical Association </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101652861 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>2374-2445 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2223742437%22">23742437 </searchLink><i>NLM ISO Abbreviation: </i>JAMA Oncol <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=42218736 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1001/jamaoncol.2026.2091 Languages: – Code: eng Text: English Titles: – TitleFull: Impact of Population-Based Pathogenic Variant Testing on Risk-Based Breast Screening Recommendations: A Secondary Analysis of the WISDOM Study. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Shieh Y – PersonEntity: Name: NameFull: Heise RS – PersonEntity: Name: NameFull: Madlensky L – PersonEntity: Name: NameFull: Sabacan LP – PersonEntity: Name: NameFull: Soto IA – PersonEntity: Name: NameFull: Fiscalini AS – PersonEntity: Name: NameFull: Ross K – PersonEntity: Name: NameFull: Goodman D – PersonEntity: Name: NameFull: Blanco A – PersonEntity: Name: NameFull: Brain S – PersonEntity: Name: NameFull: Heditsian DM – PersonEntity: Name: NameFull: Moya J – PersonEntity: Name: NameFull: Fergus KB – PersonEntity: Name: NameFull: Olopade OI – PersonEntity: Name: NameFull: Scheuner MT – PersonEntity: Name: NameFull: Eklund M – PersonEntity: Name: NameFull: Ziv E – PersonEntity: Name: NameFull: Tice JA – PersonEntity: Name: NameFull: van 't Veer L – PersonEntity: Name: NameFull: Esserman LJ IsPartOfRelationships: – BibEntity: Dates: – D: 31 M: 05 Text: 2026 May 31 Type: published Y: 2026 Identifiers: – Type: issn-electronic Value: 2374-2445 Titles: – TitleFull: JAMA oncology Type: main |
| ResultId | 1 |